Thomas Schall
Director/Board Member at IMMUNEERING CORPORATION
Net worth: 8 381 $ as of 2024-03-30
Profile
Thomas J.
Schall is the founder of ChemoCentryx, Inc., a company founded in 1997.
He held the title of Chairman, President & Chief Executive Officer from 2012 to 2022.
Dr. Schall is currently working as a Director at Immuneering Corp.
since 2024.
In the past, he worked as a Scientist at Genentech, Inc. and as a Principal at DNAX Research, Inc. Dr. Schall obtained a doctorate degree from Stanford University and an undergraduate degree from Northern Illinois University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-21 | 2,900 ( 0.01% ) | 8 381 $ | 2024-03-30 |
Thomas Schall active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNEERING CORPORATION | Director/Board Member | 2024-03-11 |
Former positions of Thomas Schall
| Companies | Position | End |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Executive Officer | 2022-10-19 |
| DNAX Research, Inc. | Corporate Officer/Principal | 1996-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Schall
| Stanford University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
| DNAX Research, Inc. |
- Stock Market
- Insiders
- Thomas Schall
